Herder’s resignation was followed shortly by the resignation of PMPRB Executive Director , signaling a leadership crisis at the agency. This turmoil occurred after a decade-long effort to modernize pricing rules in Canada, where drug prices remain among the highest in the world , second only to the U.S. and Switzerland. Resignations at Canada's drug pricing panel raise ... - PMC
: Herder stated the government’s actions were "largely indistinguishable in form and substance from industry talking points," leaving the regulator in an "endless tunnel with no light". Context and Fallout Resignations at Canada's drug pricing panel raise
Herder’s departure was prompted by what he described as the government’s "unwillingness to support real change" in drug pricing reform. His specific grievances included: His specific grievances included: : Herder noted that
: Herder noted that the federal government delayed the introduction of new pricing regulations four separate times, accepting industry claims that more time was needed. Resignations at Canada's drug pricing panel raise